Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial.

European Heart Journal
Michel KomajdaPhilip D Home

Abstract

Thiazolidinediones are insulin sensitizers, and are associated with fluid retention and increased risk of heart failure (HF) in people with type 2 diabetes. We assessed fatal and non-fatal HF events and their outcome, and identified HF predictors in the RECORD (Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of glycaemia in Diabetes) trial population. In a multicentre, open-label study, we randomized 4447 people with type 2 diabetes on metformin or sulfonylurea monotherapy with a mean HbA(1c) of 7.9% to add-on rosiglitazone (n = 2220) or to a combination of metformin and sulfonylurea (n = 2227) and followed them over 5.5 years on average. Heart failure hospitalizations and deaths were adjudicated by a Clinical Endpoint Committee using pre-specified criteria. Independent predictors of HF events were identified out of a group of 30 pre-specified clinical, demographic, and biological variables. In the rosiglitazone group, the risk of HF death or hospitalization was doubled: HR = 2.10 (95% CI, 1.35-3.27): the excess HF event rate was 2.6 (1.1-4.1) per 1000 person-years. An excess in HF deaths was observed (10 vs. two), including four HF deaths as first HF events. By contrast, there was no increase in cardiovascular mort...Continue Reading

References

Apr 24, 2001·Diabetes Care·E J Mayer-Davis
Jun 8, 2001·Circulation·C IribarrenJ V Selby
Aug 9, 2001·European Heart Journal·W J RemmeUNKNOWN Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology
Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Apr 23, 2003·Journal of the American College of Cardiology·W H Wilson TangJames B Young
Aug 19, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Guizhu HongJohn Brown
Sep 10, 2003·Mayo Clinic Proceedings·Asra Kermani, Abhimanyu Garg
Oct 12, 2004·The Journal of Pharmacology and Experimental Therapeutics·Lihong ChenKathleen K Brown
Jul 9, 2005·The Journal of Pharmacology and Experimental Therapeutics·Irina G Kessova, Arthur I Cederbaum
Apr 14, 2006·Cleveland Clinic Journal of Medicine·W H Wilson Tang
Nov 10, 2006·Journal of the American Society of Nephrology : JASN·Janaka KarallieddeUNKNOWN Rosiglitazone Fluid Retention Study Group
May 23, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·P D HomeUNKNOWN RECORD Study Group
Aug 20, 2009·BMJ : British Medical Journal·David N JuurlinkMuhammad M Mamdani
Aug 20, 2009·BMJ : British Medical Journal·Corinne S de Vries, David L Russell-Jones

❮ Previous
Next ❯

Citations

Aug 13, 2013·Current Hypertension Reports·Stefan Engeli, Jens Jordan
Feb 1, 2011·Revista española de cardiología·Óscar Díaz-CastroManuel Martínez-Sellés
Feb 16, 2010·European Heart Journal·Steven E Nissen
Mar 17, 2012·European Heart Journal·Faiez ZannadBertram Pitt
Oct 28, 2010·Diabetes, Obesity & Metabolism·G Schernthaner, R J Chilton
Jun 18, 2011·The Journal of Endocrinology·Victor P BilanStevan P Tofovic
Jun 15, 2011·World Journal of Cardiology·Siripong PaleeNipon Chattipakorn
Feb 1, 2013·Current Diabetes Reviews·Dionysios V Chartoumpekis, Thomas W Kensler
Oct 4, 2012·Expert Review of Cardiovascular Therapy·Yabin WangFeng Cao
Dec 3, 2014·Journal of the American College of Cardiology·Robert J MentzChristopher M O'Connor
Dec 26, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wai Kwan LauTengku Sifzizul Tengku Muhammad
Oct 25, 2012·The American Journal of Cardiology·Saifullah Nasir, David Aguilar
Oct 2, 2012·Diabetes Research and Clinical Practice·André J Scheen
Jan 5, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Ganesh V HaladeGabriel Fernandes
Nov 26, 2015·Journal of Diabetes and Its Complications·John McMurray
Oct 21, 2010·The Mount Sinai Journal of Medicine, New York·Amulya T SiramMaria Skamagas
Sep 16, 2010·Cardiovascular Therapeutics·Pantelis A SarafidisAnastasios N Lasaridis
Sep 15, 2012·European Journal of Heart Failure·Anselm K GittDiethelm Tschöpe
Apr 6, 2016·Frontiers in Bioengineering and Biotechnology·Ya-Ju ChangChia-Ching Wu
Jun 26, 2015·Cardiovascular Therapeutics·Vun Heng ChongChim C Lang
Dec 12, 2012·European Journal of Pharmacology·Bianca HemmeryckxHenri R Lijnen
Jul 9, 2010·PPAR Research·Tamás Roszer, Mercedes Ricote
Jul 15, 2015·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·B A KappelM Federici
May 27, 2015·Lancet·Richard E Gilbert, Henry Krum
Jun 3, 2015·Current Cardiology Reports·Barbara E StähliJean-Claude Tardif
Apr 10, 2015·Cardiovascular Diabetology·Jesús Fuentes-AntrásÓscar Lorenzo
Jun 12, 2013·Journal of the American College of Cardiology·Clyde W YancyUNKNOWN American Heart Association Task Force on Practice Guidelines
Feb 18, 2015·Diabetes Research and Clinical Practice·Ying WangThomas H Marwick
Sep 11, 2012·Biochimica Et Biophysica Acta·Natasha Fillmore, Gary D Lopaschuk
Nov 19, 2011·American Heart Journal·David Aguilar
Dec 10, 2014·International Journal of Clinical Pharmacy·Narjes Saheb Sharif-AskariAli Al Sayed Hussain

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT00379769

Software Mentioned

SAS
PROactive
RECORD

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.